IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2004;45:1281-1288.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0671

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amin, S.
Right arrow Articles by Luthert, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amin, S.
Right arrow Articles by Luthert, P. J.

Modulation of Sub-RPE Deposits In Vitro: A Potential Model for Age-Related Macular Degeneration

Sepideh Amin,1 N. H. Victor Chong,1 Tracey A. Bailey,1 Jinjun Zhang,2 Carlo Knupp,3 Michael E. Cheetham,1 John Greenwood,2 and Philip J. Luthert1

1From the Divisions of Pathology and 2Cell Biology, Institute of Ophthalmology, University College, London, United Kingdom; and the 3Biological Structure and Function Section, Biomedical Sciences Division, Imperial College, London, United Kingdom.

PURPOSE. Sub-RPE deposits form in a variety of conditions most notably in age-related macular degeneration. The purpose of this study was to generate sub-RPE deposits in vitro and to test the hypotheses that high protein concentrations or retinal homogenate increase deposit formation and that a challenge with tumor necrosis factor (TNF)-{alpha} or metalloproteinase (MMP)-2 decreases such deposits.

METHODS. ARPE-19 cells were grown on plastic and on collagen type I–coated membrane inserts in media containing various concentrations of fetal calf serum (FCS), bovine serum albumin, or porcine retinal homogenate. In addition, cells grown on membrane inserts were treated with TNF-{alpha} or MMP-2. Sub-RPE deposits were assessed by electron microscopy and classified into fibrillar, condensed, banded, and membranous subtypes. The area of the micrograph occupied by each type was estimated with a point-counting technique. MMP-2 activity was assessed in tissue culture supernatants by zymography.

RESULTS. With increasing time in culture, total deposit formation did not change, but the amount of condensed material deposited by ARPE-19 cells increased while the fibrillar component decreased. Albumin challenge resulted in an increased amount of deposit, predominantly of the membranous type. Challenge with retinal homogenate led to a greater net deposit formation with significant increases in the condensed and banded forms. Cells treated with TNF-{alpha} or MMP-2 showed a dramatic reduction in all types of sub-RPE deposit. Zymography demonstrated that unchallenged cells produced predominantly MMP-2. Retinal homogenate challenge reduced the total amount of active MMP-2 produced, and TNF-{alpha} stimulated MMP-9 production.

CONCLUSIONS. Sub-RPE deposits formed in vitro share ultrastructural features with those seen in vivo. Deposit formation can be modulated by challenge with retinal homogenate, TNF-{alpha}, or MMP-2. Significantly, the results provide proof of the principle that sub-RPE deposits can be formed and modified in vitro.





This article has been cited by other articles:


Home page
Am J EpidemiolHome page
R. L. Seitzman, V. B. Mahajan, C. Mangione, J. A. Cauley, K. E. Ensrud, K. L. Stone, S. R. Cummings, M. C. Hochberg, T. A. Hillier, J. S. Sinsheimer, et al.
Estrogen Receptor Alpha and Matrix Metalloproteinase 2 Polymorphisms and Age-related Maculopathy in Older Women
Am. J. Epidemiol., May 15, 2008; 167(10): 1217 - 1225.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. S. Boekhoorn, J. R. Vingerling, A. G. Uitterlinden, J. B. J. Van Meurs, C. M. van Duijn, H. A. P. Pols, A. Hofman, and P. T. V. M. de Jong
Estrogen Receptor {alpha} Gene Polymorphisms Associated with Incident Aging Macula Disorder
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1012 - 1017.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology